Impact of Restricted Phosphorus, Calcium-adjusted Diet on Musculoskeletal and Mental Health in Hypophosphatasia.

dietary calcium dietary phosphorus fatigue hypophosphatasia pain physical function

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Dec 2023
Historique:
received: 12 09 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: epublish

Résumé

Impairments in musculoskeletal and mental health are common in adults with Hypophosphatasia (HPP). Restricted phosphorus intake has been suggested to positively affect symptoms in HPP, but there is a lack of interventional evidence. This work aimed to evaluate the effect of a phosphorus-restricted, calcium-adjusted diet on musculoskeletal and mental health in HPP. A prospective, noncontrolled, single-center interventional study (NuSTEPS II) was conducted among outpatients at the Osteology Department, University of Wuerzburg, Germany. A total of 26 adults with an established HPP diagnosis received a standardized diet with a defined daily intake of phosphorus (1160-1240 mg/d) and calcium (870-930 mg/d) over 8 weeks. Main outcome measures were functional testing and patient-reported outcome measures. At 8 weeks, significant improvements were observed in usual gait speed ( Adjusting phosphorus and calcium intake may positively affect individual symptoms in adults with HPP, but overall clinical effectiveness regarding major issues like pain and endurance appears limited.

Identifiants

pubmed: 38111621
doi: 10.1210/jendso/bvad150
pii: bvad150
pmc: PMC10726311
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvad150

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.

Auteurs

Katinka Kuehn (K)

Faculty of Natural Science, Institute of Food Science and Human Nutrition, Leibniz University Hannover, 30167 Hanover, Germany.

Andreas Hahn (A)

Faculty of Natural Science, Institute of Food Science and Human Nutrition, Leibniz University Hannover, 30167 Hanover, Germany.

Lothar Seefried (L)

Clinical Trial Unit, Orthopedic Institute, Koenig-Ludwig-Haus, University of Wuerzburg, 97074 Wuerzburg, Germany.

Classifications MeSH